Gog carboplatin
WebMethods: An analysis of patients treated with carboplatin and paclitaxel on Gynecologic Oncology Group (GOG) protocol 158 was performed. The dose of carboplatin for each … http://carbo-g.com/
Gog carboplatin
Did you know?
WebAug 4, 2024 · Phase 3 double-blind, placebo-controlled, multi-center study to compare the safety and efficacy of four administrations of oregovomab 2 mg IV versus placebo, administered in combination with specific cycles of a standard six-cycle chemotherapy regimen (paclitaxel and carboplatin), for the treatment of subjects with newly diagnosed … WebThis randomized phase III trial studies how well cisplatin or carboplatin (platinum based chemotherapy) works compared to capecitabine in treating patients with remaining …
WebGOG-158 Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology … WebThe chemotherapy-only regimen consisted of carboplatin (to achieve an AUC of 6) plus paclitaxel at a dose of 175 mg per square meter every 21 days for six cycles. In the …
WebMar 16, 2024 · The GOG-0213 trial is an open-label, phase 3, multicenter, international, randomized clinical trial designed to assess two clinically relevant hypotheses: that bevacizumab added to paclitaxel and... WebThe GOG Foundation is a nonprofit organization dedicated to transforming the standard of care in gynecologic oncology. We conduct clinical and translational research that …
WebNov 20, 2024 · The Gynecologic Oncology Group studied carboplatin plus paclitaxel (TC) as a noninferior alternative to TAP. Methods: GOG0209 was a phase III, randomized, noninferiority, open-label trial. Inclusion criteria were stage III, stage IV, and recurrent endometrial cancers; performance status 0-2; and adequate renal, hepatic, and marrow …
WebPalbociclib with Cisplatin or Carboplatin in Treating Patients with Advanced Solid Tumors. Status . Completed. Cancer Type . Breast Cancer Lung Cancer Pancreatic Cancer Solid … jeana pvpWebMay 20, 2012 · The AUC statistics (range 0.52-0.64) show that the log (CrCl J) was not a good predictor of grade ≥3 AE (anemia, thrombocytopenia, febrile neutropenia, auditory, … jeana prestonWebApr 17, 2024 · On the basis of the GOG experience, 85% of patients treated with pelvic RT were expected to be alive and recurrence free at 36 months. Reduction in the recurrence/death hazard of 49% would increase the 36-month RFS to 92% (absolute difference, 7%). jean appsWebCarboplatin AUC 5 + Peglyated liposomal doxorrubicin (PLD) After 4 cycles: CR by RECIST v1.1 and CA125<35. Starts maintenance with Niraparib in May 2024. Second Progression March 2024 (TFIp 2 years): CT scan: signifcant size increased axilary and retroperitoneal lymph-nodes. Ca-125: 561 U/mL. Third therapy line in March 2024: jeanapvpWebFeb 13, 2024 · Go to Brief Summary: A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer. Detailed Description: jeana pronunciationWebApr 9, 2024 · Of 102 patients enrolled between June 12, 2024, and April 11, 2024, 101 received at least one dose of tisotumab vedotin. One enrolled patient had a serious … jean appWebCalculation for carboplatin dose (Calvert Equation): Dose (mg) = Target AUC [ (GFR +25)] Ideal Body Weight: 45.5 + [2.3 x (number of inches over 5ft tall)] for females 50 + [2.3 x (number of inches over 5ft tall)] for males Adjusted Body Weight: ( (Actual Body Weight - Ideal Body Weight) x 0.40) + Ideal Body Weight BMI jeana pvp discord